Related Experiment Video
Updated: Jul 16, 2026
Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Glutamate measurement in Parkinson's disease using MRS at 3 T field strength
Nils Kickler1, Paul Krack, Valérie Fraix
1INSERM, U594, Neuroimagerie fonctionnelle et métabolique, Grenoble, France. Nils.Kickler@ujf-grenoble.fr
Abstract:
Loss of nigral dopamine neurons in Parkinson's disease induces abnormal activation of glutamate systems in the basal ganglia. The purpose of this study was to assess these changes in the lentiform nucleus using MRS with optimized glutamate sensitivity (TE-averaged method). Ten patients with Parkinson's disease and 10 healthy controls were examined. Compared with healthy controls, no significant differences in glutamate were measured in patients, but a trend to lower total creatine was observed.
